[An urgent call for raising the scientific rigorousness of clinical trials on COVID-19]

Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Mar 10;41(3):301-302. doi: 10.3760/cma.j.issn.0254-6450.2020.03.004.

[Article in Chinese]

Authors

F Chen¹, Y T Hao², Z J Zhang³, J L Tang⁴, J L Xia⁵, S Y Zhan⁶, Y Zhao¹, Z C Du², Y Y Wei¹, S P Shen¹, Q W Jiang³, L M Li⁶

Affiliations

¹ Nanjing Medical University, Nanjing 211166, China.
² Sun Yat-sen University, Guangzhou 510080, China.
³ Fudan University, Shanghai 200032, China.
⁴ Guangzhou Women and Children's Medical Centre, Guangzhou 510623, China.
⁵ Air Force Military Medical University, Xi'an 710032, China.
⁶ Peking University, Beijing 100191, China.

PMID: 32294824
DOI: 10.3760/cma.j.issn.0254-6450.2020.03.004

No abstract available

MeSH terms

Betacoronavirus
COVID-19
Clinical Trials as Topic / standards*
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2